Advanced search
Publication Cover
Clinical Ophthalmology Volume 17, 2023 - Issue
Submit an article Journal homepage
198
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Prospective Study of Cyclosporine A 0.1% Combined with Loteprednol 0.2% vs Cyclosporine A 0.05% Alone in the Treatment of Dry Eye

John Hovanesian1 Harvard Eye Associates, Laguna Hills, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8060-8750View further author information
ORCID Icon,
Thomas Chester2 Cleveland Eye Clinic, Cleveland, OH, USAORCID Iconhttps://orcid.org/0000-0002-9078-6670View further author information
ORCID Icon &
Robert C Sorenson3 Inland Eye Specialists, Hemet, CA, USAView further author information
Pages 2181-2191 | Received 17 May 2023, Accepted 07 Jul 2023, Published online: 02 Aug 2023

References

  • Farrand F, Fridman M, Stillman IÖ, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol. 2017;182:90–98. doi:10.1016/j.ajo.2017.06.033
  • Hovanesian JA, Epitropoulos A, Donnenfeld ED, Holladay JT. The effect of lifitegrast on refractive accuracy and symptoms in dry eye patients undergoing cataract surgery. Clin Ophthalmol. 2020;14:2709–2716. doi:10.2147/OPTH.S264520
  • McCormick GJ, Porter J, Cox IG, MacRae S. Higher-order aberrations in eyes with irregular corneas after laser refractive surgery. Ophthalmology. 2005;112:1699–1709. doi:10.1016/j.ophtha.2005.04.022
  • Williams D. Visual benefit of correcting higher order aberrations of the eye. J Refr Surg. 2013;16(5):S554–S559.
  • Matossian C, Trattler W, Loh J. Matossian, dry eye treatment with topical cyclosporine 0.1% in chondroitin sulfate ophthalmic emulsion. Clin Ophthalmol. 2021;15:1979–1984. doi:10.2147/OPTH.S308088
  • Bron A, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640–650. doi:10.1097/00003226-200310000-00008
  • Ngo W, Situ P, Keir N, Korb D, Blackie C, Simpson T. Psychometric properties and validation of the standard patient evaluation of eye dryness questionnaire. Cornea. 2013;32(9):1204–1210. doi:10.1097/ICO.0b013e318294b0c0
  • Schulze M, Jones DA, Simpson TL. The development of validated bulbar redness grading scales. Optomet Vis Sci. 2007;84(10):976–983. doi:10.1097/OPX.0b013e318157ac9e
  • Lee JH, Kee CW. The significance of tear film break-up time in the diagnosis of dry eye syndrome. Korean J Ophthalmol. 1988;2:69–71. doi:10.3341/kjo.1988.2.2.69
  • Stelmack JA, Massof RW. Using the VA LV VFQ-48 and LV VFQ-20 in low vision rehabilitation. Optomet Vis Sci. 2007;84(8):705–709. doi:10.1097/OPX.0b013e3181339f1a
  • Wilson S, Perry HD. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment. Ophthalmology. 2007;114(1):76–79. doi:10.1016/j.ophtha.2006.05.077
  • Sheppard J, Scoper SV, Samudre S. Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease. J Ocul Pharmacol Therap. 2011;27(1):23–27. doi:10.1089/jop.2010.0085
  • Mah F, Donnenfeld E, Conway T, et al. PERSIST: physician’s evaluation of restasis® satisfaction in second trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review. Clin Ophthalmol;2012. 1971–1976. doi:10.2147/OPTH.S30261
  • Perry Henry D, Solomon R, Donnenfeld ED, et al. Evaluation of topical cyclosporine for the treatment of dry eye disease. Arch Ophthalmol. 2008;126(8):1046–1050. doi:10.1001/archopht.126.8.1046
  • Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology. 2000;107(4):631–639. doi:10.1016/S0161-6420(99)00176-1

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.